These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16758469)

  • 1. Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model.
    Larson AC; Rhee TK; Deng J; Wang D; Sato KT; Salem R; Paunesku T; Woloschak G; Mulcahy MF; Li D; Omary RA
    J Magn Reson Imaging; 2006 Jul; 24(1):242-7. PubMed ID: 16758469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two different injection rates of gadoxetic acid for arterial phase MRI of the liver.
    Chung SH; Kim MJ; Choi JY; Hong HS
    J Magn Reson Imaging; 2010 Feb; 31(2):365-72. PubMed ID: 20099350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of gadobenate dimeglumine on MRI of mouse liver metastasis model constructed by orthotopic transplantation of highly metastatic murine colon carcinoma (C38-OT7): comparison with gadopentetate dimeglumine].
    Yoshikawa K; Takamura T; Funahashi Y; Senba T; Ogawa T; Ono H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jul; 59(8):380-5. PubMed ID: 10459282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ; Runge VM; Biswas J; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time MRI monitoring of transcatheter hepatic artery contrast agent delivery in rabbits.
    Sato KT; Larson AC; Rhee TK; Salem RA; Nemcek AA; Mounajjed T; Paunesku T; Woloschak G; Nikolaides P; Omary RA
    Acad Radiol; 2005 Oct; 12(10):1342-50. PubMed ID: 16179211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison study of intraarticular and intravenous gadolinium-enhanced magnetic resonance imaging of cartilage in a canine model.
    Kwack KS; Cho JH; Kim M MS; Yoon CS; Yoon YS; Choi JW; Kwon JW; Min BH; Sun JS; Kim SY
    Acta Radiol; 2008 Feb; 49(1):65-74. PubMed ID: 17963083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
    Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y
    Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
    Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
    J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-directed MR angiography and cross-sectional imaging for the assessment of renal artery stenosis.
    Omary RA; Schirf BE; Green JD; Kanwar YS; Shea SM; Carroll TJ; Carr J; Li D
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):255-60. PubMed ID: 15713927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced MR imaging of postoperative scars and VX2 carcinoma in rabbits: comparison of macromolecular contrast agent and gadopentetate dimeglumine.
    Lee JW; Moon WK; Weinmann HJ; Kim SJ; Kim JH; Park SH; Kim TJ; Yoon CJ; Kim YH; Cho EY; Ha SW; Kang WS; Chang KH
    Radiology; 2003 Oct; 229(1):132-9. PubMed ID: 14519873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging.
    Lauenstein TC; Sharma P; Hughes T; Heberlein K; Tudorascu D; Martin DR
    J Magn Reson Imaging; 2008 Jun; 27(6):1448-54. PubMed ID: 18504735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gd-DTPA enhanced multi-shot echo-planar MRI: improvement of contrast between metastatic liver cancer and liver parenchyma].
    Kim T; Murakami T; Takahashi S; Okada A; Hori M; Nobuhiro M; Tomoda K; Narumi Y; Oi H; Nakamura H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Apr; 58(5):235-7. PubMed ID: 9617159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MR imaging of VX2 carcinomas after X-irradiation in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent.
    Kim YH; Choi BI; Cho WH; Lim S; Moon WK; Han JK; Weinmann HJ; Chang KH
    Invest Radiol; 2003 Sep; 38(9):539-49. PubMed ID: 12960523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MR imaging of bacterial abscess and VX2 carcinoma in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent.
    Moon WK; Chang KH; Weinmann HJ; Koh YH; Im JG; Yeon KM; Han MC
    AJR Am J Roentgenol; 2000 May; 174(5):1385-90. PubMed ID: 10789800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.